Summary
Machine-generated summaryThe National Institute of Diabetes, Nutrition and Metabolic Diseases 'N. C. Paulescu' in Romania awarded a framework agreement for the supply of medicines for the National Diabetes Programme. The products covered include empagliflozin 10 mg, metformin 1000 mg, Tresiba (insulin degludec), Fiasp (fast-acting insulin aspart), dulaglutide, dapagliflozin 10 mg, empagliflozin plus metformin 5 mg/1000 mg, dapagliflozin plus metformin 5 mg/1000 mg and semaglutide in 1.5 mg, 4 mg and 9 mg strengths. The winner was ALLIANCE HEALTHCARE ROMANIA. The estimated value is EUR 284,675.32. Subsequent contracts will be concluded depending on the budget funds allocated, and the framework agreement runs for 24 months.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 weeks ago
More from this buyer
Full buyer profileRecent awards
- România - Medicamente pentru diabet - Acord cadru furnizare medicamente pentru Programul National de Diabet
- România - Consumabile medicale - Acord cadru de furnizare Sistem de monitorizare glicemica continua - pachet initiere
- Acord cadru furnizare medicamente pentru PROGRAMUL NATIONAL DE SUPLEERE A FUNCTIEI RENALE
Similar tenders
1
day left
€169,005
est. value
1
day left
€616,850
est. value
1
day left
€172,767,852
est. value
1
day left
€2,071,619
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,020,608
- Buyer track record on Aperlena
- 19 notices tracked · 12 awarded
- €208,403 in awarded contracts
Never miss a tender like this
320 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.
Set up my alert